Initially, the identification of the endogenous RNA targets of MEX3D was performed in cervical cancer cells by high-throughput RNA immunoprecipitation (RIP) sequencing (analyzed by RiboBio, Guangzhou, China). Here, MEX3D is linked to cervical carcinoma.